Response to OSTP’s Request for Information on the Development of an AI Action Plan
Stanford scholars respond to a federal RFI on the development of an AI Action Plan, urging policymakers to promote open and scientific innovation, craft evidence-based AI policy, and empower government leaders.
In collaboration with
Executive Summary
In this response to a request for information issued by the National Science Foundation’s Networking and Information Technology Research and Development National Coordination Office (on behalf of the Office of Science and Technology Policy) regarding the development of an AI Action Plan, scholars from Stanford HAI, the Center for Research on Foundation Models (CRFM), and the Regulation, Evaluation, and Governance Lab (RegLab) urge policymakers to prioritize four areas of policy action:
Promote open innovation as a strategic advantage for U.S. competitiveness;
Maintain U.S. AI leadership by promoting scientific innovation;
Craft evidence-based AI policy that protects Americans without stifling innovation;
Empower government leaders with resources and technical expertise to ensure a “whole-of-government” approach to AI governance.
Related Publications
Response to OSTP's Request for Information on Accelerating the American Scientific Enterprise
Stanford scholars respond to a federal RFI on scientific discovery, calling for the government to support a new “team science” academic research model for AI-enabled discovery.
Stanford scholars respond to a federal RFI on scientific discovery, calling for the government to support a new “team science” academic research model for AI-enabled discovery.
Response to FDA's Request for Comment on AI-Enabled Medical Devices
Stanford scholars respond to a federal RFC on evaluating AI-enabled medical devices, recommending policy interventions to help mitigate the harms of AI-powered chatbots used as therapists.
Stanford scholars respond to a federal RFC on evaluating AI-enabled medical devices, recommending policy interventions to help mitigate the harms of AI-powered chatbots used as therapists.
Russ Altman’s Testimony Before the U.S. Senate Committee on Health, Education, Labor, and Pensions
In this testimony presented to the U.S. Senate Committee on Health, Education, Labor, and Pensions hearing titled “AI’s Potential to Support Patients, Workers, Children, and Families,” Russ Altman highlights opportunities for congressional support to make AI applications for patient care and drug discovery stronger, safer, and human-centered.
In this testimony presented to the U.S. Senate Committee on Health, Education, Labor, and Pensions hearing titled “AI’s Potential to Support Patients, Workers, Children, and Families,” Russ Altman highlights opportunities for congressional support to make AI applications for patient care and drug discovery stronger, safer, and human-centered.
Michelle M. Mello's Testimony Before the U.S. House Committee on Energy and Commerce Health Subcommittee
In this testimony presented to the U.S. House Committee on Energy and Commerce’s Subcommittee on Health hearing titled “Examining Opportunities to Advance American Health Care through the Use of Artificial Intelligence Technologies,” Michelle M. Mello calls for policy changes that will promote effective integration of AI tools into healthcare by strengthening trust.
In this testimony presented to the U.S. House Committee on Energy and Commerce’s Subcommittee on Health hearing titled “Examining Opportunities to Advance American Health Care through the Use of Artificial Intelligence Technologies,” Michelle M. Mello calls for policy changes that will promote effective integration of AI tools into healthcare by strengthening trust.